Completed PHASE3 INTERVENTIONAL 2-arm NCT01273883

A Trial of Magnesium Dependent Tinnitus

A Phase III Trial of Magnesium Dependent Tinnitus

Sponsor: Mayo Clinic

Conditions Tinnitus

Updated 5 times since 2017 Last updated: Apr 9, 2015 Started: Jul 31, 2011 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01273883, this PHASE3 trial focuses on Tinnitus and remains completed. Sponsored by Mayo Clinic, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Scottsdale, United States